$KPTI has been mentioned 4 times over the past 12 months by 2 distinct FinTwit voices, with @jacobplieth leading discussion at 3 mentions and @adamfeuerstein contributing 1 mention. The first mention appeared on 2026-02-13, with the most recent activity on 2026-04-30. Discussion has centered on Karyopharm's clinical trial data and conference presentations, particularly around the Sentry trial and ASCO26 late-breaker embargo dynamics.